PMID- 24491075 OWN - NLM STAT- MEDLINE DCOM- 20151116 LR - 20220409 IS - 1939-2117 (Electronic) IS - 0022-006X (Print) IS - 0022-006X (Linking) VI - 82 IP - 3 DP - 2014 Jun TI - Mindfulness-oriented recovery enhancement for chronic pain and prescription opioid misuse: results from an early-stage randomized controlled trial. PG - 448-459 LID - 10.1037/a0035798 [doi] AB - OBJECTIVE: Opioid pharmacotherapy is now the leading treatment for chronic pain, a problem that affects nearly one third of the U.S. population. Given the dramatic rise in prescription opioid misuse and opioid-related mortality, novel behavioral interventions are needed. The purpose of this study was to conduct an early-stage randomized controlled trial of Mindfulness-Oriented Recovery Enhancement (MORE), a multimodal intervention designed to simultaneously target mechanisms underpinning chronic pain and opioid misuse. METHOD: Chronic pain patients (N = 115; mean age = 48 +/- 14 years; 68% female) were randomized to 8 weeks of MORE or a support group (SG). Outcomes were measured at pre- and posttreatment, and at 3-month follow-up. The Brief Pain Inventory was used to assess changes in pain severity and interference. Changes in opioid use disorder status were measured by the Current Opioid Misuse Measure. Desire for opioids, stress, nonreactivity, reinterpretation of pain sensations, and reappraisal were also evaluated. RESULTS: MORE participants reported significantly greater reductions in pain severity (p = .038) and interference (p = .003) than SG participants, which were maintained by 3-month follow-up and mediated by increased nonreactivity and reinterpretation of pain sensations. Compared with SG participants, participants in MORE evidenced significantly less stress arousal (p = .034) and desire for opioids (p = .027), and were significantly more likely to no longer meet criteria for opioid use disorder immediately following treatment (p = .05); however, these effects were not sustained at follow-up. CONCLUSIONS: Findings demonstrate preliminary feasibility and efficacy of MORE as a treatment for co-occurring prescription opioid misuse and chronic pain. (PsycINFO Database Record (c) 2014 APA, all rights reserved). FAU - Garland, Eric L AU - Garland EL AD - College of Social Work. FAU - Manusov, Eron G AU - Manusov EG AD - Duke Southern Regional Area Health Education Center. FAU - Froeliger, Brett AU - Froeliger B AUID- ORCID: 0000-0001-9451-9900 AD - Department of Neuroscience. FAU - Kelly, Amber AU - Kelly A AD - School of Social Work, Smith College. FAU - Williams, Jaclyn M AU - Williams JM AD - College of Social Work, Florida State University. FAU - Howard, Matthew O AU - Howard MO AD - School of Social Work, University of North Carolina. LA - eng GR - R03 DA032517/DA/NIDA NIH HHS/United States GR - R34 DA037005/DA/NIDA NIH HHS/United States GR - R34DA037005/DA/NIDA NIH HHS/United States GR - R03DA032517/DA/NIDA NIH HHS/United States PT - Journal Article PT - Randomized Controlled Trial PT - Research Support, N.I.H., Extramural PT - Research Support, Non-U.S. Gov't DEP - 20140203 PL - United States TA - J Consult Clin Psychol JT - Journal of consulting and clinical psychology JID - 0136553 RN - 0 (Analgesics, Opioid) SB - IM MH - Adult MH - Aged MH - Analgesics, Opioid/*administration & dosage/*adverse effects MH - Arousal MH - Chronic Pain/drug therapy/psychology/*therapy MH - Combined Modality Therapy MH - Feasibility Studies MH - Female MH - Humans MH - Male MH - Middle Aged MH - *Mindfulness MH - Opioid-Related Disorders/*etiology/*therapy MH - Treatment Outcome MH - United States MH - Veterans PMC - PMC4076008 MID - NIHMS582118 EDAT- 2014/02/05 06:00 MHDA- 2015/11/17 06:00 PMCR- 2015/06/01 CRDT- 2014/02/05 06:00 PHST- 2014/02/05 06:00 [entrez] PHST- 2014/02/05 06:00 [pubmed] PHST- 2015/11/17 06:00 [medline] PHST- 2015/06/01 00:00 [pmc-release] AID - 2014-03888-001 [pii] AID - 10.1037/a0035798 [doi] PST - ppublish SO - J Consult Clin Psychol. 2014 Jun;82(3):448-459. doi: 10.1037/a0035798. Epub 2014 Feb 3.